🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +21.72% on $IMNM in just 19h 36m.
NPC
$NPCE
🔒 US EquitiesNeuropace Inc
AVG HISTORICAL GAP
+4.43%
MAX GAP RECORD
+23.72%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NPCE
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NPCE
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 12, 2026 Earnings Release 2026-11-12 (AFTER CLOSE (22:00)) | 🔮 UPCOMING 🔒 |
| Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE) |
-5.91%
|
| Mar 03, 2026 Earnings Release 2026-03-03 (AFTER CLOSE) |
+12.73%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
+23.72%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
-1.97%
|
| May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE) |
+10.42%
|
| Mar 04, 2025 Earnings Release 2025-03-04 (AFTER CLOSE) |
+6.12%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
+8.12%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.2%
Bullish Gaps (8)
Bearish Gaps (4)
Neutral / Flat (2)
📖 Intelligence Summary
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗